Rădulescu Cristina Ramona, Drăgănescu Anca Cristina, Băncilă Diana Maria, Bilaşco Anuţa, Bădescu Mihai-Rareş, Pleşca Doina Anca
Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
"Prof. Dr. Matei Balş" National Institute of Infectious Diseases, 021105 Bucharest, Romania.
Diagnostics (Basel). 2025 Mar 7;15(6):656. doi: 10.3390/diagnostics15060656.
Kawasaki disease (KD) is an acute inflammatory vasculitis with a particularly high incidence of coronary artery complications and constitutes a significant cause of acquired heart disease in children and young adults. We conducted a retrospective analysis of consecutive patients aged 0-18 years hospitalized at the "Prof. Dr. Matei Balş" National Institute of Infectious Diseases in Bucharest with Kawasaki disease over a period of 6 years (2018-2023). A total of 25 children were discharged from hospital with this diagnosis during the analyzed period. The mean age was 2.9 years, and 56% were boys. Fever ≥5 days was present in all cases, and the most frequent additional sign was the presence of oral changes. Patients were treated according to in-effect guidelines with intravenous immunoglobulin (IVIG) (100%) and acetylsalicylic acid (68%). Only two cases were considered IVIG resistant and received a second IVIG infusion. Only mild cardiovascular changes were noted in echocardiography: mild coronary artery dilatation (21.7% of cases), mild valvular regurgitation, and small pericardial effusion. Infants displayed less inflammation and higher percentages of leukocytosis, developed an increase in platelet count sooner, received IVIG faster, and had longer hospital stays. Outcomes were generally favorable, and 92% of children were discharged, while the two remaining patients were transferred to other centers. No deaths were recorded. To our knowledge, this is the largest contemporary Romanian cohort of Kawasaki disease published to date, outlining the local diagnostic process, therapeutic strategies, and early outcomes of Kawasaki disease.
川崎病(KD)是一种急性炎症性血管炎,冠状动脉并发症的发生率特别高,是儿童和年轻人后天性心脏病的重要病因。我们对在布加勒斯特的“马泰·巴尔什教授”国家传染病研究所住院的0至18岁川崎病连续患者进行了为期6年(2018 - 2023年)的回顾性分析。在分析期间,共有25名儿童因该诊断出院。平均年龄为2.9岁,56%为男孩。所有病例均有≥5天的发热,最常见的附加体征是口腔改变。患者按照无效指南接受静脉注射免疫球蛋白(IVIG)(100%)和乙酰水杨酸(68%)治疗。仅两例被认为对IVIG耐药并接受了第二次IVIG输注。超声心动图仅发现轻度心血管改变:轻度冠状动脉扩张(21.7%的病例)、轻度瓣膜反流和少量心包积液。婴儿炎症较轻,白细胞增多症百分比更高,血小板计数升高更快,接受IVIG更快,住院时间更长。总体预后良好,92%的儿童出院,其余两名患者转至其他中心。无死亡记录。据我们所知,这是迄今为止发表的最大的当代罗马尼亚川崎病队列研究,概述了川崎病的当地诊断过程、治疗策略和早期预后。